Letters to the editor
Prevalence and mortality prognosis of steatotic liver disease phenotypes
Zhiyu Sun
Department of Cardiology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Qingdao Municipal Key Laboratory of Hypertension (Key Laboratory of Cardiovascular Medicine), Qingdao, Shandong, China
Chinese patient-oriented metabolic and ischemic risk evaluation (CREAT) study, Qingdao, Shandong, China
Chi Zhou
Department of Cardiology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Chinese patient-oriented metabolic and ischemic risk evaluation (CREAT) study, Qingdao, Shandong, China
Yiwen Zhang
Department of Endocrinology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Pengfei Li
Department of General Practice, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Junjie Guo
Corresponding author
Department of Cardiology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Qingdao Municipal Key Laboratory of Hypertension (Key Laboratory of Cardiovascular Medicine), Qingdao, Shandong, China
Chinese patient-oriented metabolic and ischemic risk evaluation (CREAT) study, Qingdao, Shandong, China
Zhexun Lian
Department of Cardiology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Tsinghua Medicine, Tsinghua University, Beijing, China
Department of Cardiology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Qingdao Municipal Key Laboratory of Hypertension (Key Laboratory of Cardiovascular Medicine), Qingdao, Shandong, China
Chinese patient-oriented metabolic and ischemic risk evaluation (CREAT) study, Qingdao, Shandong, China
Read
324
Timeswas read the article
127
Total PDF
197
Total HTML
Share statistics
array:23 [ "pii" => "S1665268124002813" "issn" => "16652681" "doi" => "10.1016/j.aohep.2024.101487" "estado" => "S300" "fechaPublicacion" => "2024-05-01" "aid" => "101487" "copyright" => "Fundación Clínica Médica Sur, A.C." "copyrightAnyo" => "2024" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Ann Hepatol. 2024;29:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:17 [ "pii" => "S1665268124002825" "issn" => "16652681" "doi" => "10.1016/j.aohep.2024.101488" "estado" => "S300" "fechaPublicacion" => "2024-05-01" "aid" => "101488" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Ann Hepatol. 2024;29:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:9 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letters to the editor</span>" "titulo" => "MASLD identifies patients with significant hepatic fibrosis and steatosis in fatty liver population" "tienePdf" => "en" "tieneTextoCompleto" => "en" "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0001" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2459 "Ancho" => 3333 "Tamanyo" => 311476 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0001" "detalle" => "Fig " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spara001" class="elsevierStyleSimplePara elsevierViewall">The characteristics of MASLD patients. (A) Venn diagram in the population with fatty liver. (B) Comparison of liver steatosis scores and fibrosis scores between MASLD and Non-MASLD steatosis patients. *** <span class="elsevierStyleItalic">p</span> < 0.001.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "You Deng, Wenya Chen, Wen Xie" "autores" => array:3 [ 0 => array:2 [ "nombre" => "You" "apellidos" => "Deng" ] 1 => array:2 [ "nombre" => "Wenya" "apellidos" => "Chen" ] 2 => array:2 [ "nombre" => "Wen" "apellidos" => "Xie" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268124002825?idApp=UINPBA00004N" "url" => "/16652681/0000002900000003/v1_202404281202/S1665268124002825/v1_202404281202/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S1665268124002801" "issn" => "16652681" "doi" => "10.1016/j.aohep.2024.101486" "estado" => "S300" "fechaPublicacion" => "2024-05-01" "aid" => "101486" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Ann Hepatol. 2024;29:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:8 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letters to the editor</span>" "titulo" => "Impact of new fatty liver disease nomenclature on primary care— cerebration of gastroenterologists in a regional tertiary care hospital" "tienePdf" => "en" "tieneTextoCompleto" => "en" "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Xingcen Chen, Deliang Liu, Rong Li" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Xingcen" "apellidos" => "Chen" ] 1 => array:2 [ "nombre" => "Deliang" "apellidos" => "Liu" ] 2 => array:2 [ "nombre" => "Rong" "apellidos" => "Li" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268124002801?idApp=UINPBA00004N" "url" => "/16652681/0000002900000003/v1_202404281202/S1665268124002801/v1_202404281202/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letters to the editor</span>" "titulo" => "Prevalence and mortality prognosis of steatotic liver disease phenotypes" "tieneTextoCompleto" => true "saludo" => "To the editor," "autores" => array:7 [ 0 => array:3 [ "autoresLista" => "Zhiyu Sun" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Zhiyu" "apellidos" => "Sun" ] ] "afiliaciones" => array:3 [ 0 => array:2 [ "entidad" => "Department of Cardiology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China" "identificador" => "aff0001" ] 1 => array:2 [ "entidad" => "Qingdao Municipal Key Laboratory of Hypertension (Key Laboratory of Cardiovascular Medicine), Qingdao, Shandong, China" "identificador" => "aff0002" ] 2 => array:2 [ "entidad" => "Chinese patient-oriented metabolic and ischemic risk evaluation (CREAT) study, Qingdao, Shandong, China" "identificador" => "aff0003" ] ] ] 1 => array:3 [ "autoresLista" => "Chi Zhou" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Chi" "apellidos" => "Zhou" ] ] "afiliaciones" => array:2 [ 0 => array:2 [ "entidad" => "Department of Cardiology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China" "identificador" => "aff00011" ] 1 => array:2 [ "entidad" => "Chinese patient-oriented metabolic and ischemic risk evaluation (CREAT) study, Qingdao, Shandong, China" "identificador" => "aff02003" ] ] ] 2 => array:3 [ "autoresLista" => "Yiwen Zhang" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Yiwen" "apellidos" => "Zhang" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Department of Endocrinology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China" "identificador" => "aff0004" ] ] ] 3 => array:3 [ "autoresLista" => "Pengfei Li" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Pengfei" "apellidos" => "Li" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Department of General Practice, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China" "identificador" => "aff0005" ] ] ] 4 => array:4 [ "autoresLista" => "Junjie Guo" "autores" => array:1 [ 0 => array:4 [ "nombre" => "Junjie" "apellidos" => "Guo" "email" => array:1 [ 0 => "guojunjie@qdu.edu.cn" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0001" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:2 [ "entidad" => "Department of Cardiology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China" "identificador" => "aff02001" ] 1 => array:2 [ "entidad" => "Qingdao Municipal Key Laboratory of Hypertension (Key Laboratory of Cardiovascular Medicine), Qingdao, Shandong, China" "identificador" => "aff00202" ] 2 => array:2 [ "entidad" => "Chinese patient-oriented metabolic and ischemic risk evaluation (CREAT) study, Qingdao, Shandong, China" "identificador" => "aff00303" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0001" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] 5 => array:3 [ "autoresLista" => "Zhexun Lian" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Zhexun" "apellidos" => "Lian" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Department of Cardiology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China" "identificador" => "aff23001" ] ] ] 6 => array:4 [ "autoresLista" => "Hongwei Ji" "autores" => array:1 [ 0 => array:4 [ "nombre" => "Hongwei" "apellidos" => "Ji" "email" => array:1 [ 0 => "hongweijicn@tsinghua.edu.cn" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "fn1" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">**</span>" "identificador" => "cor0002" ] ] ] ] "afiliaciones" => array:4 [ 0 => array:2 [ "entidad" => "Tsinghua Medicine, Tsinghua University, Beijing, China" "identificador" => "aff000f4" ] 1 => array:2 [ "entidad" => "Department of Cardiology, the Affiliated Hospital of Qingdao University, Qingdao, Shandong, China" "identificador" => "aff00a01" ] 2 => array:2 [ "entidad" => "Qingdao Municipal Key Laboratory of Hypertension (Key Laboratory of Cardiovascular Medicine), Qingdao, Shandong, China" "identificador" => "aff001402" ] 3 => array:2 [ "entidad" => "Chinese patient-oriented metabolic and ischemic risk evaluation (CREAT) study, Qingdao, Shandong, China" "identificador" => "aff000f3" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0002" "etiqueta" => "⁎⁎" "correspondencia" => "Corresponding author." ] ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="para0003" class="elsevierStylePara elsevierViewall">We read the new nomenclature for steatotic liver disease (SLD) with great interest <a class="elsevierStyleCrossRef" href="#bib0001">[1]</a>. Given the existence of phenotypic heterogeneity of fatty liver, the extent to which these innovative SLD phenotypes (i.e., metabolic dysfunction-associated steatotic liver disease [MASLD], alcohol-related liver disease [ALD], and an overlap of the 2 [MetALD]) were associated with adverse events remains unclear.</p><p id="para0004" class="elsevierStylePara elsevierViewall">We utilized data from the Third National Health and Nutrition Examination Survey (NHANES III), which comprised data on ultrasonography-measured steatosis <a class="elsevierStyleCrossRef" href="#bib0002">[2]</a>. The ethical review board of the National Center for Health Statistics approved the implementation of NHANES. Each participant provided information on alcohol consumption through a questionnaire <a class="elsevierStyleCrossRef" href="#bib0002">[2]</a>. In NHAENS, a drink means a 12-oz beer, a 4-oz glass of wine, or an ounce of liquor, which could be converted to 14 grams of pure alcohol <a class="elsevierStyleCrossRef" href="#bib0003">[3]</a>. In this study, as suggested by the consensus <a class="elsevierStyleCrossRef" href="#bib0001">[1]</a>, MetALD patients were classified into a category distinct from MASLD to capture the pathogenic value of alcohol consumption and prognostic implications <a class="elsevierStyleCrossRef" href="#bib0001">[1]</a>. Participants were followed for the all-cause mortality by the National Death Index records were reviewed on December 31, 2019.</p><p id="para0005" class="elsevierStylePara elsevierViewall">Our analysis included 6279 participants from NHANES III who were then categorized into five groups: (1) MASLD, <span class="elsevierStyleItalic">N</span>=872, (2) MetALD, <span class="elsevierStyleItalic">N</span>=141, (3) ALD, <span class="elsevierStyleItalic">N</span>=64, (4) Other SLD, <span class="elsevierStyleItalic">N</span>=108, and (5) Participants without hepatic steatosis, <span class="elsevierStyleItalic">N</span>=5094. We used a multivariable-adjusted Cox proportional hazard regression model to assess the association of these SLD phenotypes with all-cause mortality, with models accounting for demographic and cardiometabolic risk factors. P values were 2-sided and considered significant at 0.05. All analyses were performed by using R, version 4.2.1.</p><p id="para0006" class="elsevierStylePara elsevierViewall">As shown in <a class="elsevierStyleCrossRef" href="#tbl0001">Table 1</a>, in this large and nationally representative US cohort consisting of 6279 adults (age 48.1±20, 53 % female), the prevalence of MASLD was 13.8 %, MetALD was 2.2 % and ALD was 1.0. After a median follow-up of 26.9 years, 1892 all-cause deaths were documented. We observed that ALD was significantly associated with a 69 % higher hazard of all-cause mortality (hazard ratio [95 % confidence interval], 1.69 [1.18–2.41], <span class="elsevierStyleItalic">P</span><0.001) when compared with healthy controls, while the association between other SLD phenotypes and mortality are neutral (<span class="elsevierStyleItalic">P for all</span> >0.1).</p><elsevierMultimedia ident="tbl0001"></elsevierMultimedia><p id="para0007" class="elsevierStylePara elsevierViewall">Previous studies have demonstrated the association between metabolic dysfunction associated with fatty liver disease and all-cause mortality <a class="elsevierStyleCrossRef" href="#bib0002">[2]</a>. However, as metabolic dysfunction related to fatty liver disease does not entirely exclude ALD <a class="elsevierStyleCrossRef" href="#bib0004">[4]</a>, the role of alcohol intake in SLD patients remains unclear. Our study expanded prior findings and, for the first time, showed that, for SLD patients, alcohol intake may play a more critical role than metabolic dysfunction in association with all-cause mortality. Considering that alcohol consumption was one of the leading causes of death and disability worldwide <a class="elsevierStyleCrossRef" href="#bib0005">[5]</a>. Our study further highlights the impact of alcohol consumption on mortality in SLD patients. Restricting alcohol consumption may be a crucial measure in reducing the mortality of SLD patients. The new nomenclature may provide important insights into risk stratification from an alcohol-related pathophysiological pathway. It should be noted that the population studied in the NHANES III database was examined between 1988 and 1994; the dynamic evolution of SLD during follow up was not captured in this study. More studies are warranted to validate our findings.</p><span id="sec0002" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0003">Author contributions</span><p id="para0009" class="elsevierStylePara elsevierViewall">HJ, ZS, JG-Conceptualization, HJ, ZS - Data curation, HJ, ZS- Formal analysis, HJ- Funding acquisition, All authors- Investigation, All authors - Methodology, JG - Project administration, JG, HJ- Resources, HJ, ZS- Software, HJ- Supervision, HJ- Validation, HJ- Visualization, All authors- Writing - original draft, All authors - Writing - review & editing.</p></span><span id="sec0003" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0004">Funding</span><p id="para0010" class="elsevierStylePara elsevierViewall">This study was funded in part by the <span class="elsevierStyleGrantSponsor" id="gs0001">National Natural Science Foundation of China</span> (Grant ID. <span class="elsevierStyleGrantNumber" refid="gs0001">82103908</span>), the <span class="elsevierStyleGrantSponsor" id="gs0002">Taishan Scholar Program of Shandong Province</span> (<span class="elsevierStyleGrantNumber" refid="gs0002">tsqn202211364</span>) and the Shandong Provincial Natural Science Foundation (ZR2021QH014). The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p></span><span id="coi0001" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="cesectitle0005">Declaration of interests</span><p id="para0011" class="elsevierStylePara elsevierViewall">None.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0002" "titulo" => "Author contributions" ] 1 => array:2 [ "identificador" => "sec0003" "titulo" => "Funding" ] 2 => array:2 [ "identificador" => "coi0001" "titulo" => "Declaration of interests" ] 3 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2023-07-26" "fechaAceptado" => "2024-01-28" "NotaPie" => array:1 [ 0 => array:3 [ "etiqueta" => "1" "nota" => "<p class="elsevierStyleNotepara" id="notep0001">Last authors.</p>" "identificador" => "fn1" ] ] "multimedia" => array:1 [ 0 => array:8 [ "identificador" => "tbl0001" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0001" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:3 [ "leyenda" => "<p id="spara002" class="elsevierStyleSimplePara elsevierViewall">MASLD, metabolic dysfunction-associated steatotic liver disease; ALD, alcohol-related liver disease; CI, confidence interval.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><a name="en0001"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0002"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">Overall \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0003"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">No Steatosis \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0004"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">MASLD<a class="elsevierStyleCrossRef" href="#tb1fn1">*</a> \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0005"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">MetALD<a class="elsevierStyleCrossRef" href="#tb1fn1">*</a> \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0006"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">ALD \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0007"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">Other SLD \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0008"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">P \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><a name="en0009"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top"><span class="elsevierStyleItalic">N</span> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0010"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">6279 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0011"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">5094 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0012"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">872 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0013"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">141 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0014"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">64 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0015"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">108 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0016"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0017"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">Events, n (%) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0018"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">1892 (30.1) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0019"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">1472 (28.9) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0020"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">310 (35.6) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0021"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">67 (47.5) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0022"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">32 (50.0) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0023"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">11 (10.2) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0024"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="top"><0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0025"></a><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="" valign="top">Adjusted Hazard Ratio<a class="elsevierStyleCrossRef" href="#tb1fn2"><span class="elsevierStyleSup">#</span></a> (95% CI) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0026"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">- \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0027"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Reference \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0028"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">0.94 (0.82, 1.06) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0029"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">1.19 (0.93, 1.52) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0030"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">1.69 (1.18, 2.41) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0031"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">0.86 (0.47, 1.56) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0032"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="top">0.029 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab3522022.png" ] ] ] "notaPie" => array:2 [ 0 => array:3 [ "identificador" => "tb1fn1" "etiqueta" => "⁎" "nota" => "<p class="elsevierStyleNotepara" id="notep0003">The five cardiometabolic criteria evaluated as specified by Rinella <span class="elsevierStyleItalic">et al</span>. (1) Systolic blood pressure ≥ 130 mmHg or diastolic ≥ 85 mmHg, or use of antihypertensive medication. (2) Blood glucose ≥ 100 mg/dL or HbA1c ≥ 6.5%, or presence of type 2 diabetes or diabetes treatment. (3) BMI ≥ 25 or waist circumference > 94 cm (males), > 80 cm (females). (4) HDL cholesterol ≤ 40 mg/dL (males), ≤ 50 mg/dL (females), or lipid-lowering treatment. (5) Triglycerides ≥ 150 mg/dL or intake of lipid therapy.</p> <p class="elsevierStyleNotepara" id="notep0004">Other SLD represents those who had non-alcoholic SLD without metabolic dysfunction.</p>" ] 1 => array:3 [ "identificador" => "tb1fn2" "etiqueta" => "#" "nota" => "<p class="elsevierStyleNotepara" id="notep0005">Models adjusted for age, sex, current smoking, systolic blood pressure, antihypertensives, diabetes mellitus, diabetic medication, body mass index, total cholesterol, high-density lipoprotein cholesterol, lipid lowering therapy, race and family income.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spara001" class="elsevierStyleSimplePara elsevierViewall">Prevalence and mortality prognosis of steatotic liver disease phenotypes.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "cebibsec1" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0001" "etiqueta" => "[1]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A multi-society Delphi consensus statement on new fatty liver disease nomenclature" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "ME Rinella" 1 => "JV Lazarus" 2 => "V Ratziu" 3 => "SM Francque" 4 => "AJ Sanyal" 5 => "F Kanwal" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jhep.2023.06.003" "Revista" => array:2 [ "tituloSerie" => "J Hepatol" "fecha" => "2023" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0002" "etiqueta" => "[2]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "D Kim" 1 => "P Konyn" 2 => "KK Sandhu" 3 => "BB Dennis" 4 => "AC Cheung" 5 => "A. Ahmed" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jhep.2021.07.035" "Revista" => array:6 [ "tituloSerie" => "J Hepatol" "fecha" => "2021" "volumen" => "75" "numero" => "6" "paginaInicial" => "1284" "paginaFinal" => "1291" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0003" "etiqueta" => "[3]" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "<a target="_blank" href="https://www.niaaa.nih.gov/alcohols-effects-health/overview-alcohol-consumption/what-standard-drink#:~:text=In%20the%20United%20States%2C%20one%20%22standard%22%20drink%20%28or,of%20distilled%20spirits%2C%20which%20is%20about%2040%25%20alcohol">https://www.niaaa.nih.gov/alcohols-effects-health/overview-alcohol-consumption/what-standard-drink#:∼:text=In%20the%20United%20States%2C%20one%20%22standard%22%20drink%20%28or,of%20distilled%20spirits%2C%20which%20is%20about%2040%25%20alcohol</a>." ] ] ] 3 => array:3 [ "identificador" => "bib0004" "etiqueta" => "[4]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M Eslam" 1 => "PN Newsome" 2 => "SK Sarin" 3 => "QM Anstee" 4 => "G Targher" 5 => "M Romero-Gomez" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jhep.2020.03.039" "Revista" => array:6 [ "tituloSerie" => "J Hepatol" "fecha" => "2020" "volumen" => "73" "numero" => "1" "paginaInicial" => "202" "paginaFinal" => "209" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0005" "etiqueta" => "[5]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "MG Griswold" 1 => "N Fullman" 2 => "C Hawley" 3 => "N Arian" 4 => "SRM Zimsen" 5 => "HD Tymeson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(18)31310-2" "Revista" => array:7 [ "tituloSerie" => "Lancet" "fecha" => "2018" "volumen" => "392" "numero" => "10152" "paginaInicial" => "1015" "paginaFinal" => "1035" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30146330" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/16652681/0000002900000003/v1_202404281202/S1665268124002813/v1_202404281202/en/main.assets" "Apartado" => array:4 [ "identificador" => "82754" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/16652681/0000002900000003/v1_202404281202/S1665268124002813/v1_202404281202/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268124002813?idApp=UINPBA00004N" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 5 | 0 | 5 |
| 2024 October | 9 | 7 | 16 |
| 2024 September | 17 | 21 | 38 |
| 2024 August | 25 | 15 | 40 |
| 2024 July | 17 | 23 | 40 |
| 2024 June | 33 | 15 | 48 |
| 2024 May | 32 | 11 | 43 |
| 2024 April | 32 | 9 | 41 |
| 2024 March | 21 | 10 | 31 |
| 2024 February | 6 | 16 | 22 |
